Funded Tech Companies

Phenomix

Wondering who backed Phenomix? Presidio Partners, 5AM Ventures and private investors joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Phenomix is a drug discovery and development company building a therapeutic portfolio for treatment of immune disease and metabolic syndrome.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/31/2010

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Laura Shawver

        

Chief Medical Officer

Hans-Peter Guler

        

Vice President

Angela Birchler

        

Vice President

Marie O'Farrell

        

VP - Finance

Brian Baker

        

Company Investors

• Presidio Partners (Karl Handelsman)
• 5AM Ventures (John Diekman)
• Delphi Ventures (Deepika Pakianathan)
• Panorama Capital (Damion Wicker)
• Alta Partners (Daniel Janney)
• Novartis BioVenture Fund
• Baker Brothers Investments
• JPMorgan Partners (Srinivas Akkaraju)
• Bay City Capital (John Diekman)
• Pinnacle Ventures
• Sofinnova Ventures (Nicola Campbell)
• Delphi Ventures (Deepa Pakianathan)
• Nomura Phase4 Ventures (Denise Pollard-Knight)
• Baker Capital
• Versant Ventures
• Sofinnova Ventures (James Healy)

Browse more funded tech companies:

Phenomic AI | Phenomix Sciences

Share this article

About Our Venture Capital Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary